Colossal's AI maps about 2,300 dodo gene-editing targets for testing

Colossal CEO Ben Lamm says GenoMorph uses data from more than 70 bird species to prioritize edits; the predictions still need to be tested in the lab.

By · Published

Primary source: TechCrunch

Why it matters

GenoMorph shows how Colossal is turning de-extinction research into computational biology infrastructure. Its 2,300 dodo targets are a starting point for experiments, not validated edits or proof of a commercial product.

A dodo skeleton rests beside bird-feather specimens and sealed lab tubes beneath a Colossal Biosciences sign.

Colossal Biosciences co-founder and CEO Ben Lamm says Colossal has built an AI platform to help researchers choose which genetic changes to test as it works toward recreating dodo traits. The system, called GenoMorph, has surfaced approximately 2,300 candidate targets, according to TechCrunch's report on the October 14th announcement.…

Reader comments

Conversation for this story loads after sign-in.